In the past week, GRCE stock has gone down by -19.19%, with a monthly decline of -14.29% and a quarterly plunge of -0.93%. The volatility ratio for the week is 8.67%, and the volatility levels for the last 30 days are 9.45% for Grace Therapeutics Inc The simple moving average for the past 20 days is -15.91% for GRCE’s stock, with a 2.91% simple moving average for the past 200 days.
Is It Worth Investing in Grace Therapeutics Inc (NASDAQ: GRCE) Right Now?
The stock has a 36-month beta value of 1.37. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for GRCE is 6.25M, and at present, short sellers hold a 0.61% of that float. On January 31, 2025, the average trading volume of GRCE was 62.09K shares.
GRCE) stock’s latest price update
The stock of Grace Therapeutics Inc (NASDAQ: GRCE) has decreased by -8.62 when compared to last closing price of 3.48.Despite this, the company has seen a loss of -19.19% in its stock price over the last five trading days.
Analysts’ Opinion of GRCE
B. Riley FBR, on the other hand, stated in their research note that they expect to see GRCE reach a price target of $2. The rating they have provided for GRCE stocks is “Buy” according to the report published on July 06th, 2020.
GRCE Trading at -14.27% from the 50-Day Moving Average
After a stumble in the market that brought GRCE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -35.95% of loss for the given period.
Volatility was left at 9.45%, however, over the last 30 days, the volatility rate increased by 8.67%, as shares sank -17.40% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -3.93% lower at present.
During the last 5 trading sessions, GRCE fell by -19.19%, which changed the moving average for the period of 200-days by -6.61% in comparison to the 20-day moving average, which settled at $3.78. In addition, Grace Therapeutics Inc saw -14.97% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for GRCE
Equity return is now at value -18.89, with -16.17 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 6.01.
Conclusion
To sum up, Grace Therapeutics Inc (GRCE) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
